Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancerNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
BMC Cancer|February 2, 2013
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cellsNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2011
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activationEdit Kovalcsik, Katie Lowe, Mike Fischer, et al.
International Journal of Oncology|January 20, 2016
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibitionNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Immunology and Cell Biology|June 26, 2013
Tripartite immune cell co-operation in the Bacillus Calmette Guérin-induced activation of γδ T cellsDaniel W Fowler, John Copier, Angus G Dalgleish, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2017
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent mannerDaniel W Fowler, John Copier, Angus G Dalgleish, et al.
Intervirology|July 19, 2005
Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cellsAngelo G Scibetta, John Copier, Angela Barrett, et al.
Immunology|June 11, 2014
Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homingDaniel W Fowler, John Copier, Angus G Dalgleish, et al.
Oncology Reports|October 25, 2024
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinomaOzlem Sherif, Said A Khelwatty, Izhar Bagwan, et al.
Melanoma Research|December 4, 2004
Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patientEdit Kovalcsik, Justin John, Matthew Turner, et al.
Pageof 12